SCHEMBL20109150

SCHEMBL20109150

C=C(C(C)c1ccccc1)P1(=O)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.36
ELOVL1 Q9BW60 2/20 0.35
KCNQ2 O43526 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GFER P55789 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TP53 P04637 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPC1 O15118 1/20 0.35
PGR P06401 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
NFKB1 P19838 1/20 0.35
DRD1 P21728 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109134 0.86 DHODH (0.33) CYP2D6KDM4EALDH1A1GFERL3MBTL1
SCHEMBL20109250 0.82 CYP2D6 (0.36) CYP2D6ELOVL1KCNQ2KDM4EALDH1A1
SCHEMBL20109219 0.82 ATM (0.37) CYP2D6ELOVL1KCNQ2KDM4EALDH1A1
SCHEMBL20109131 0.77 CYP2C19 (0.35) KDM4EALDH1A1SMN1; SMN2LMNACYP2C19
SCHEMBL17596724 0.77 KMT2A (0.34) KCNQ2KDM4EALDH1A1TP53KMT2A
SCHEMBL17596436 0.75 GAA (0.39) ALDH1A1SMN1; SMN2KMT2AMEN1LMNA
SCHEMBL20109140 0.73 CHRNA7 (0.36) ALDH1A1KMT2AMEN1LMNANPC1
SCHEMBL20109145 0.72 ALDH1A1 (0.41) ALDH1A1L3MBTL1SMN1; SMN2KMT2AMEN1
SCHEMBL20109272 0.72 GAA (0.40) KDM4EALDH1A1KMT2AMEN1LMNA
SCHEMBL20109215 0.70 ATM (0.33) CYP2D6KDM4EALDH1A1GFERL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 CYP2D6 3429/4885ELOVL1 3869/4885KCNQ2 1927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.